Storia in 17 fonti

Why Is Bristol-Myers Squibb Stock Surging Monday? - Bristol-Myers Squibb (NYSE:BMY), AstraZeneca (NYSE:AZ

Bristol Myers Squibb and AstraZeneca in talks for a $400B mega-merger, potentially creating the world's 4th-largest drugmaker.

Raccontata da

www1.folha.uol.com.br

independent.co.uk+5 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo17 h fa

Why Is Bristol-Myers Squibb Stock Surging Monday? - Bristol-Myers Squibb (NYSE:BMY), AstraZeneca (NYSE:AZ

AstraZeneca and Bristol-Myers Squibb in merger talks (~$400B); AZN becomes world's 4th pharma. BMY's Anthropic partnership for AI drug discovery signals foundation models as biotech standard—manager tech should track life sciences compute scaling and AI-driven R&D governance.

originale

Timeline cronologica

domenica 2 agosto 2026·www1.folha.uol.com.br
AstraZeneca negocia fusão com Bristol Myers Squibb em acordo de US$ 400 bi
Acordo pode criar a quarta maior farmacêutica do mundo por capitalização de mercado
domenica 2 agosto 2026·cnbc.com
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

Why Is Bristol-Myers Squibb Stock Surging Monday? - Bristol-Myers Squibb (NYSE:BMY), AstraZeneca (NYSE:AZ

Confronto fonti

Why Is Bristol-Myers Squibb Stock Surging Monday? - Bristol-Myers Squibb (NYSE:BMY), AstraZeneca (NYSE:AZ

Timeline cronologica

AstraZeneca negocia fusão com Bristol Myers Squibb em acordo de US$ 400 bi

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

AstraZeneca Stock Nosedives On Mega-Merger Rumor

AstraZeneca, BMS discuss $400B pharma mega-deal

$400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A "Head Scratcher"

AstraZeneca said to have explored Bristol Myers merger | Fortune

AstraZeneca, Bristol Myers are in talks about merger — report

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca said to have explored Bristol Myers merger | Fortune

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

Media, AstraZeneca tratta con Bristol Myers Squibb: maxi fusione da 400 miliardi

Ft, AstraZeneca tratta con Bristol Myers Squibb maxi fusione da 400 miliardi

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Astrazeneca explores $400bn megadeal with US rival

AstraZeneca in talks over £300bn mega-merger with US rival – reports

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

Financial Times: 'AstraZeneca tratta con Bristol Myers Squibb per una maxi fusione da 400 miliardi' - Notizie - Ansa.it

AstraZeneca, BMS discuss $400B pharma mega-deal

AstraZeneca e Bristol Myers trattano la maxi fusione, può nascere un colosso farmaceutico da 400 miliardi | MilanoFinanza News

Las farmacéuticas AstraZeneca y Bristol Myers Squibb negocian una fusión de 348.000 millones de euros

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’

Ft: «AstraZeneca tratta con Bristol Myers Squibb per una maxi fusione da 400 miliardi» - Lettera43

Astrazeneca giù a Londra, per Ft tratta una mega-fusione con Bristol Myers Squibb